Week 8 - Phamacokinetics Following an Extravascular Dose Flashcards
How does the absorption process contribute to plasma conc-time profile following an extravascular route of drug adminsitration
How does the plasma-conc profile differ to IV bolus plasma conc.
- conc. starts at 0 gradually increases till reaches a peak (drug moving into plasma)
- IV bolus starts at high conc.
- increases as absorption is dominating
- sometimes have tlag (lag time) = delay between administration of drug + drug appearance in plasma / systemic circulation
- After peak, conc. declines (elimination dominatating)
HARD to tell if profile is absortion limited or elimination limited = COMPARE profile to IV profile (always elimination limited ~ terminal phas)
With extravscular administartion need to consider:
- Disintegration
- Dissolution
- Absorption
- Permeability
- 1st pass metabolism (loss / delay of drug in gut and liver)
ALL occur before dug reaches site of measurement (from its site of administration)
How to calculate Clearance (CL) following extravascular dosing
(F x D) / AUC
F = bioavailabilty
D = dose
CL is the same whether drug is administered IV or EV
How to calculate Volume of distribution (V) following extravascular dosing
How to calculate Elimination half-life (t1/2) following extravascular dosing
t1/2 = ln2 / k
ln2 = 0.693
How does changes in Bioavailabilty (F) affect plasma-conc. profile
As increase F:
- Cmax will increase
- AUC will change
- Tmax will remain SAME
What is ka and how does changing ka affect the plasma-conc. profile
ka = rate of absorption
IF ↓ ka:
- Cmax will ↓
- Tmax will ↑
- AUC remains unchanged
What is dissolution rate-limited absorption
Slow dissolution BUT high permeability
- when drug dissolves + gets into solution will cross intestinal wall + be absorbed
PROBLEM: drug takes time to disintegrate + appear in solution
What is permeability rate-limited absorption
Rapid dissolution BUT low permeability
- drug disintegrates + appears in solution quickly
PROBLEM: is drug crossing the membrane
- unable to cross intestinal wall + get absorbed
- delay in drug trasfer from absorption site to site of measurement